NIPT - Basic (NON-CE IVD) | Test for Trisomy 21, 18, 13, Sex Chromosome Abnormalities & Gender

The Non-Invasive Prenatal Test (NIPT) - Basic (NON-CE IVD) screens for common chromosomal abnormalities including:

• - Trisomy 21 (Down Syndrome)
• - Trisomy 18
• - Trisomy 13
• - Sex chromosome abnormalities
• - Fetal gender determination

This test uses just 10 mL of maternal blood, collected in a special tube provided by Lifenity. It is valid from 10 weeks of gestation onwards.

Why You Need This Test

NIPT is an essential screening for expecting parents seeking peace of mind about their baby’s health. It is:

• - Non-invasive and safe for both mother and baby
• - Highly accurate for detecting genetic disorders
• - Performed early in pregnancy (from 10 weeks)
• - A powerful alternative to riskier invasive tests like amniocentesis

Symptoms or Risk Factors That Indicate the Need for This Test

• - Mother’s age is 35 years or older
• - Abnormal findings on a prenatal ultrasound
• - Family history of genetic or chromosomal disorders
• - Positive results from first-trimester screenings
• - Previous pregnancy affected by chromosomal conditions

Understanding Natural Fetal Chromosome Development

Most pregnancies result in a typical number of chromosomes, but errors can occur during fetal development. These errors may lead to conditions such as:

• - Down Syndrome (Trisomy 21)
• - Edwards Syndrome (Trisomy 18)
• - Patau Syndrome (Trisomy 13)
• - Sex chromosome abnormalities like Turner or Klinefelter syndrome

NIPT analyzes fetal DNA from the mother's blood, providing early detection with high accuracy and no risk to the fetus.

What Happens If It Goes Undiagnosed?

• - Potential emotional and medical distress later in pregnancy
• - Lack of preparedness for medical care or interventions at birth
• - Increased difficulty in making informed decisions
• - Delayed access to genetic counseling or supportive care

Early screening allows timely action and better prenatal care planning.